IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CHIODELLI, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.257
EU - Europa 1.955
AS - Asia 1.721
SA - Sud America 350
AF - Africa 35
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.347
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.190
PL - Polonia 946
SG - Singapore 633
CN - Cina 517
BR - Brasile 285
UA - Ucraina 204
IT - Italia 164
DE - Germania 162
VN - Vietnam 161
HK - Hong Kong 156
FI - Finlandia 109
FR - Francia 78
GB - Regno Unito 73
TR - Turchia 58
IE - Irlanda 43
RU - Federazione Russa 40
IN - India 39
BD - Bangladesh 34
CA - Canada 31
AR - Argentina 27
AU - Australia 27
ID - Indonesia 23
JP - Giappone 20
SE - Svezia 20
AT - Austria 18
BE - Belgio 18
MX - Messico 18
CZ - Repubblica Ceca 17
ES - Italia 14
NL - Olanda 14
ZA - Sudafrica 13
VE - Venezuela 10
IQ - Iraq 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
LT - Lituania 8
PK - Pakistan 8
EC - Ecuador 7
JO - Giordania 7
MA - Marocco 7
AZ - Azerbaigian 6
SA - Arabia Saudita 6
IL - Israele 5
PA - Panama 5
PT - Portogallo 5
CR - Costa Rica 4
UZ - Uzbekistan 4
CH - Svizzera 3
CY - Cipro 3
EE - Estonia 3
IR - Iran 3
KZ - Kazakistan 3
NG - Nigeria 3
PE - Perù 3
PY - Paraguay 3
RO - Romania 3
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
CO - Colombia 2
ET - Etiopia 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PH - Filippine 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
ZM - Zambia 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KI - Kiribati 1
LU - Lussemburgo 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 7.347
Salva come PNG Salva come JPEG
Città #
Warsaw 944
Ashburn 358
Singapore 314
Fairfield 313
Woodbridge 180
Hong Kong 155
Houston 154
Jacksonville 149
San Jose 143
Chandler 139
Cambridge 131
Ann Arbor 120
Seattle 118
Beijing 112
Wilmington 107
New York 88
The Dalles 87
Princeton 80
Los Angeles 78
Helsinki 75
Brescia 67
Dallas 63
Munich 56
Nanjing 45
Council Bluffs 44
Ho Chi Minh City 43
Dong Ket 40
Dublin 40
Lauterbourg 40
Istanbul 39
Dearborn 37
São Paulo 35
San Francisco 26
Buffalo 25
Chicago 25
Hanoi 25
Shanghai 24
Phoenix 20
San Diego 20
Santa Clara 20
Tokyo 19
Brussels 18
Redondo Beach 18
Des Moines 17
Jakarta 17
Milan 17
Jinan 16
Turku 16
London 15
Nuremberg 15
Hangzhou 14
Hebei 14
Orem 14
Stockholm 14
Brooklyn 13
Atlanta 12
Denver 12
Montreal 12
Moscow 12
Nanchang 12
Guangzhou 11
Jiaxing 11
Tianjin 11
Changsha 10
Johannesburg 10
Brno 9
Leawood 9
Zhengzhou 9
Amsterdam 8
Ankara 8
Chennai 8
Dhaka 8
Frankfurt am Main 8
Kocaeli 8
Mexico City 8
Shenyang 8
Vienna 8
Haikou 7
Poplar 7
Rio de Janeiro 7
Turin 7
Baku 6
Boardman 6
Manchester 6
Ningbo 6
Prague 6
Redwood City 6
Salt Lake City 6
Taizhou 6
Toronto 6
Amman 5
Belo Horizonte 5
Charlotte 5
Curitiba 5
Kunming 5
Lancaster 5
Mumbai 5
Paris 5
San Mateo 5
Vancouver 5
Totale 5.160
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 363
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 319
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 308
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 304
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 278
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 270
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 251
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 229
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 216
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 189
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 187
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 186
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 181
Sialic acid as a target for the development of novel antiangiogenic strategies 175
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 171
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 166
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 163
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 153
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 147
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 145
Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway 144
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 139
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 139
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 135
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 133
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 130
Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor 121
Long-pentraxin 3 affects primary cilium in zebrafish embryo and cancer cells via the fgf system 117
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis 116
Heparan-sulfate proteoglycans mediate the angiogenic activity of the novel VEGFR2 agonist gremlin 113
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 107
Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines 107
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 107
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells 104
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 99
Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma 99
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin 94
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration 89
BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF THE INTERACTION OF GREMLIN (Drm) WITH HEPARIN/HEPARAN SULFATE PROTEOGLYCANS 87
Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis 85
HIV-1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension of its biological functions 83
implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study 77
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 77
Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase 72
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice 70
HIV-1 Tat and heparan sulfate proteoglycans orchestrate the setup of in cis and in trans cells surface interactions functional to lymphocyte trans-endothelial migration 66
Dataset: Impact of β-Galactosylceramidase Overexpression on the Protein Profile of Braf(V600E) Mutated Melanoma Cells 62
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 61
HIV-of its biological functions1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension 60
implementation of an incremental docking method to study long sugar chains interactions with proteins 59
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 56
direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound 51
Totale 7.460
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.731
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 0 0 54
2021/2022385 31 65 11 11 4 20 29 23 27 41 29 94
2022/2023391 52 8 20 16 32 96 5 42 62 2 32 24
2023/2024416 23 9 42 22 13 74 14 24 88 27 24 56
2024/20251.052 17 7 6 130 73 89 62 59 78 106 247 178
2025/20262.265 202 278 183 344 247 205 278 90 165 173 76 24
Totale 7.460